2015
DOI: 10.1530/endoabs.37.gp.29.06
|View full text |Cite
|
Sign up to set email alerts
|

The incidence of consecutive manifestations of VHL disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2016
2016
2016
2016

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
1
1
0
Order By: Relevance
“…Retinal lesions are the earliest and most frequent manifestation (present in 49%-68% of cases), but the condition is also associated with life-threatening tumors, including renal cell carcinoma, pheochromocytoma, and cerebellar hemangioblastoma. 2 Oninvestigation,thispatientrevealedthatherfatherhasVHL,consistent with his history of retinal detachment. Genetic testing for a VHL gene mutation on chromosome 3 and retinal biopsy are not necessary in this case as multiple RCHs are diagnostic for VHL disease; however, genetic counseling may help this patient understand the risk to living relativesandoffspring.Genetictestingmaybeavaluablescreeningtool for patients with solitary lesions or a negative family history.…”
Section: Discussionsupporting
confidence: 53%
See 1 more Smart Citation
“…Retinal lesions are the earliest and most frequent manifestation (present in 49%-68% of cases), but the condition is also associated with life-threatening tumors, including renal cell carcinoma, pheochromocytoma, and cerebellar hemangioblastoma. 2 Oninvestigation,thispatientrevealedthatherfatherhasVHL,consistent with his history of retinal detachment. Genetic testing for a VHL gene mutation on chromosome 3 and retinal biopsy are not necessary in this case as multiple RCHs are diagnostic for VHL disease; however, genetic counseling may help this patient understand the risk to living relativesandoffspring.Genetictestingmaybeavaluablescreeningtool for patients with solitary lesions or a negative family history.…”
Section: Discussionsupporting
confidence: 53%
“…Approxi-mately20%ofVHLgenemutationsaresporadic.PatientswithVHLdisease and their relatives should be screened for ocular disease and biennial systemic evaluation should include magnetic resonance imaging of the brain, pancreas, and kidneys. 2 Lifelong annual screening is rec-ommendedinthosewithVHLdiseaseandVHLgenemutationcarriers. 3 The presence of at least 1 RCH increases the risk for decreased vision, with greatest vision loss found with both juxtapapillary and peripheral locations of RCHs.…”
Section: Discussionmentioning
confidence: 99%